Wealthspire Advisors (Maryland)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-584
Closed -$17K – 873
2019
Q1
$17K Sell
584
-24
-4% -$843 ﹤0.01% 1334
2018
Q4
$18K Buy
608
+12
+2% +$381 ﹤0.01% 1238
2018
Q3
$21K Buy
596
+116
+24% +$3.6K ﹤0.01% 1290
2018
Q2
$11K Buy
480
+84
+21% +$1.78K ﹤0.01% 1495
2018
Q1
$7K Buy
396
+240
+154% +$3.55K ﹤0.01% 1673
2017
Q4
$2K Sell
156
-332
-68% -$4.32K ﹤0.01% 2108
2017
Q3
$6K Sell
488
-128
-21% -$2.26K ﹤0.01% 1726
2017
Q2
$11K Buy
616
+580
+1,611% +$10.7K ﹤0.01% 1487
2017
Q1
$1K Buy
+36
New +$703 ﹤0.01% 1789
2016
Q4
– Sell
-72
Closed -$2K – 1763
2016
Q3
$2K Buy
+72
New +$1.6K ﹤0.01% 1539
2016
Q1
– Sell
-320
Closed -$7K – 1762
2015
Q4
$7K Buy
+320
New +$6.66K ﹤0.01% 1268

Other funds holding DXCM

Wealthspire Advisors (Maryland)'s DXCM Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of DexCom (DXCM) in Q2 2019, closing a stake of 584 shares — an estimated $17K sold.

Wealthspire Advisors (Maryland) first reported a position in DXCM in Q4 2015 and held it in 11 quarters. The position peaked at $21K in Q3 2018. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 584 DexCom shares in Q2 2019, an estimated $17K.
  • Wealthspire Advisors (Maryland) first reported a position in DexCom in Q4 2015 and held it in 11 quarters.
  • Wealthspire Advisors (Maryland)'s DexCom position peaked at $21K in Q3 2018.
  • 418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.